Fused tri and tetra-cyclic pyrazole kinase inhibitors

Details Fused tri and tetra-cyclic pyrazole kinase inhibitors Fused tri and tetra-cyclic pyrazole kinase inhibitors

2004-03-03

2008-01-22

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S406000, C546S082000, C548S359500

Reexamination Certificate

active

07320986

ABSTRACT:
Compounds having the formula (I)are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 2969371 (1961-01-01), Braun et al.
patent: 2969373 (1961-01-01), Loev et al.
patent: 3004983 (1961-10-01), Loev
patent: 3843665 (1974-10-01), Coombs et al.
patent: 3843666 (1974-10-01), Coombs et al.
patent: 3932430 (1976-01-01), Habeck et al.
patent: 6291504 (2001-09-01), Nugiel et al.
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6407103 (2002-06-01), Nugiel et al.
patent: 6462036 (2002-10-01), Doyle et al.
patent: 2001/0027195 (2001-10-01), Nugiel et al.
patent: 2002/0183334 (2002-12-01), Bacon et al.
patent: 60130521 (1985-07-01), None
patent: 9917769 (1999-04-01), None
patent: 9917770 (1999-04-01), None
patent: 99/54308 (1999-10-01), None
patent: 00/27822 (2000-05-01), None
patent: 0027822 (2000-05-01), None
patent: 0059901 (2000-10-01), None
patent: 01/87846 (2001-11-01), None
patent: 0187846 (2001-11-01), None
patent: 02/44174 (2002-06-01), None
patent: 02/46182 (2002-06-01), None
patent: 02/070494 (2002-09-01), None
patent: 03/004491 (2003-01-01), None
patent: 03/007883 (2003-01-01), None
patent: 03/033499 (2003-04-01), None
patent: 03/070236 (2003-08-01), None
Nugiel et al., “Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors,” J. Med. Chem. 44:1334-1336 (2001).
Nugiel et al., “Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern,” J. Med. Chem. 45:5224-5232 (2002).
Yue et al., “Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C31,2” J. Med. Chem. 45:5233-5248 (2002).
Braun, et al., Journal of Organic Chemistry, 24, 648-650, (1959).
Braun et al, Journal of the American Chemical Society, 80, 4919-4921 (1958).
Nishida Seigj, Patent Abstracts of Japan, 009(287), C-314 (1985).

Affiliated with

Also associated with

Rating

Fused tri and tetra-cyclic pyrazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused tri and tetra-cyclic pyrazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused tri and tetra-cyclic pyrazole kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3964314